Kidney Disease May Add to Higher Risk for CVD Due to HIV
FRIDAY, Dec. 18, 2020 -- Kidney function has a strong influence on the effect of HIV serostatus on brachial artery flow-mediated dilation (FMD), a measure of endothelial function, according to a study published online Dec. 17 in Arteriosclerosis, Thrombosis, and Vascular Biology.
James H. Stein, M.D., from the University of Wisconsin School of Medicine and Public Health in Madison, and colleagues examined the effects of HIV serostatus and disease severity on endothelial function in a pooled cohort study of people living with HIV infection (986 participants) and HIV-negative controls (1,547 individuals) from nine studies.
The researchers found that brachial artery diameter, age, sex, and body mass index were the strongest and most consistent associates of FMD. Kidney function had a strong influence on the effect of HIV+ serostatus on FMD. The effect of HIV+ serostatus was strong in the highest tertile of creatinine (ß = −1.59 percent) even after adjustment for covariates (ß = −1.36 percent). The effect of HIV+ serostatus was also strong in the lowest tertile of creatinine (ß = −1.90 percent), but after covariate adjustment, this finding was longer seen. No meaningful associations with FMD were seen for HIV RNA viremia, CD4+ T-cell count, or use of antiretroviral therapy.
"We also did not expect such a large effect from kidney function on HIV patients' endothelial health," Stein said in a statement. "Even mild kidney disease might play a role in HIV-associated cardiovascular disease risk."
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
FRIDAY, Jan. 22, 2021 -- For patients with multiple myeloma (MM), those with renal insufficiency (RI) have an increased risk for disease progression or death, according to a...
TUESDAY, Jan. 19, 2021 -- For inpatients with ischemic heart disease, redesign of decision pathways from default opt-in to opt-out of cardiac rehabilitation (CR) results in a...
FRIDAY, Jan. 15, 2021 -- The decision to stop renin-angiotensin system (RAS) inhibitor therapy in patients with advanced chronic kidney disease (CKD) should take into account both...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.